Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan.
Adjuvant chemotherapy for gastric cancer has been extensively explored in Japan since the 1950s, and a combination of oral fluorinated pyrimidines (o-FP) and mitomycin C (MMC) has been mainly utilized for adjuvant chemotherapy. However, there is no sufficient evidence for the efficacy of adjuvant therapy. Therefore, we assessed the efficacy of o-FPs over surgery alone (control) by means of a meta-analysis of Japanese centrally randomized controlled clinical trials conducted between 1980 and 2005. For inclusion in this study, studies had to compare adjuvant chemotherapy for curatively resected gastric cancer with surgery alone, mainly targeting o-FP, and central randomization designed to comply with contemporary standards for clinical trials in Japan. For the 4 trials that met the eligibility criteria, the estimated hazard ratio was 0.73 (95%CI=0.60-0.89). Our findings show that in Japan adjuvant chemotherapy using o-FP for long-term maintenance therapy appears to be effective for gastric cancer patients after curative resection.
Oba
K
K
Department of Epidemiological & Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto, Japan. oba@pbh.med.kyoto-u.ac.jp
Morita
S
S
Tsuburaya
A
A
Kodera
Y
Y
Kobayashi
M
M
Sakamoto
J
J
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007564:Japan; D016685:Mitomycin / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D000903:Antibiotics, Antineoplastic; D011743:Pyrimidines; D016685:Mitomycin